Clinical Trial Update: Midostaurin in Indolent Systemic Mastocytosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for midostaurin in indolent systemic mastocytosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indolent Systemic Mastocytosis

Drugs mentioned

• Midostaurin (midostaurin)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Indolent Systemic Mastocytosis | Phase 2 | Status: UNKNOWN